These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25555732)

  • 41. Sequential Dynamics of Stearoyl-CoA Desaturase-1(SCD1)/Ligand Binding and Unbinding Mechanism: A Computational Study.
    Petroff AB; Weir RL; Yates CR; Ng JD; Baudry J
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
    Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
    Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Azacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase.
    Liu G
    Expert Opin Ther Pat; 2009 Jun; 19(6):885-91. PubMed ID: 19473107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.
    Binczek E; Jenke B; Holz B; Günter RH; Thevis M; Stoffel W
    Biol Chem; 2007 Apr; 388(4):405-18. PubMed ID: 17391062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Key role of the ERK1/2 MAPK pathway in the transcriptional regulation of the Stearoyl-CoA Desaturase (SCD1) gene expression in response to leptin.
    Mauvoisin D; Prévost M; Ducheix S; Arnaud MP; Mounier C
    Mol Cell Endocrinol; 2010 May; 319(1-2):116-28. PubMed ID: 20109524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
    Stamatikos AD; Paton CM
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in the SCD1 gene are associated with indices of stearoyl CoA desaturase activity and obesity: a prospective study.
    Martín-Núñez GM; Cabrera-Mulero R; Rojo-Martínez G; Gómez-Zumaquero JM; Chaves FJ; de Marco G; Soriguer F; Castaño L; Morcillo S
    Mol Nutr Food Res; 2013 Dec; 57(12):2177-84. PubMed ID: 23934750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation.
    Uto Y; Ogata T; Kiyotsuka Y; Miyazawa Y; Ueno Y; Kurata H; Deguchi T; Yamada M; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Konishi M; Kurikawa N; Kono K; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4159-66. PubMed ID: 19541482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structure of human stearoyl-coenzyme A desaturase in complex with substrate.
    Wang H; Klein MG; Zou H; Lane W; Snell G; Levin I; Li K; Sang BC
    Nat Struct Mol Biol; 2015 Jul; 22(7):581-5. PubMed ID: 26098317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
    Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors.
    Liu G; Lynch JK; Freeman J; Liu B; Xin Z; Zhao H; Serby MD; Kym PR; Suhar TS; Smith HT; Cao N; Yang R; Janis RS; Krauser JA; Cepa SP; Beno DW; Sham HL; Collins CA; Surowy TK; Camp HS
    J Med Chem; 2007 Jun; 50(13):3086-100. PubMed ID: 17530838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based virtual screening of natural products as potential stearoyl-coenzyme a desaturase 1 (SCD1) inhibitors.
    Huang Y; Wang H; Wang H; Wen R; Geng X; Huang T; Shi J; Wang X; Wang J
    Comput Biol Chem; 2020 Jun; 86():107263. PubMed ID: 32315834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism.
    Sampath H; Ntambi JM
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):84-8. PubMed ID: 16477170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-throughput scintillation proximity assay for stearoyl-CoA desaturase-1.
    Tawa P; Falgueyret JP; Guiral S; Isabel E; Powell DA; Zuck P; Skorey K
    J Biomol Screen; 2011 Jun; 16(5):506-17. PubMed ID: 21406617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of stearoyl-CoA desaturase in the control of metabolism.
    Dobrzyn A; Ntambi JM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
    Scaglia N; Igal RA
    Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.
    Chen C; Shah YM; Morimura K; Krausz KW; Miyazaki M; Richardson TA; Morgan ET; Ntambi JM; Idle JR; Gonzalez FJ
    Cell Metab; 2008 Feb; 7(2):135-47. PubMed ID: 18249173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.